by Garth Sundem | Dec 7, 2015 | Latest News, Research
Results of a multicenter phase 1 clinical trial presented today at the 2015 San Antonio Breast Cancer Symposium show that the anti-androgen agent enzalutamide is active and well-tolerated alone and with fulvestrant in patients with advanced breast cancer. The study...
by Tyler Smith | Jan 8, 2015 | Patient Care
The University of Colorado Cancer Center has taken important steps toward joining a small number of institutions nationwide with dedicated programs for treating and conducting research into sarcomas. Sarcomas, which are tumors that form in the bones and connective...
by Kim Chriscaden | Jul 1, 2014 | Latest News
Four University of Colorado Cancer Center investigators and Department of Medical Oncology faculty were recently promoted. Congratulations to the following: Antonio Jimeno, MD, PhD, was promoted from associate professor to professor with tenure. Anthony Elias, MD, was...
by Erika Matich | May 1, 2014 | Patient Care
A clinical trial shows that an experimental drug along with standard chemotherapy is a beneficial treatment for some women with newly diagnosed, high-risk breast cancer. University of Colorado Cancer Center is one of the institutions taking part in the trial led by UC...
